Can new OCT scanners see eye disease better?
NCT ID NCT07338461
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study will test two new eye imaging devices (R1 and HighRes OCT) against a standard device in 97 adults with healthy eyes or eye diseases like macular degeneration and diabetic retinopathy. Researchers will compare image quality and how well key eye structures are seen. The goal is to see if the new devices provide clearer, more useful images for diagnosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could lead to better imaging tools for diagnosing and monitoring eye diseases like macular degeneration and diabetic retinopathy.
- What could go wrong
- This is a small pilot study focused on image quality, not treatment. The new devices may not show clear improvement over existing technology.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Biomedical and Clinical Sciences, Luigi Sacco Hospital, University of Milan
Milan, 20157, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI eye doctor: could software catch diabetic blindness sooner?
- Can a VR maze reveal hidden vision loss in macular degeneration?
- Can eye scans reveal hidden clues about diabetes damage?
- Can a new eye injection save vision in wet AMD?
- A new eye camera may spot stressed cells before vision loss begins
- A sharper look at the retina: new imaging technology may spot eye disease earlier